| 22231 | 22231 | Prospective Clinical Trial Evaluating Metronomic Chemotherapy in Patients With High-grade, Operable, Non-metastatic Osteosarcoma of the Extremity | Recruiting | No Results Available | High Grade Osteosarcoma | Drug: continuous oral cyclophosphamide and methotrexate | https://ClinicalTrials.gov/show/NCT02273583 |
| 22232 | 22232 | Optimal Anemia Treatment in End Stage Renal Disease (ERSD) | Recruiting | No Results Available | Hyperparathyroidism, Secondary | Drug: standard care|Drug: Optimal (I. iPTH control: Zemplar®,Mimpara®; phosphorous control: Renvela®, Phoslo®, Osvaren®, Foznol®,Maalox®; calcium control: calcium and vitamin D | https://ClinicalTrials.gov/show/NCT02273570 |
| 22233 | 22233 | Bioavailability of Dipyridamole of Asasantin p.o. in Three Experimental Formulations Relative to the Standard Formulation in Healthy Male Subjects | Completed | No Results Available | Healthy | Drug: Asasantin ER (new formulation I - low)|Drug: Asasantin ER (new formulation III - medium)|Drug: Asasantin ER (new formulation II - high)|Drug: Asasantin ER (present commercial formulation) | https://ClinicalTrials.gov/show/NCT02273557 |
| 22234 | 22234 | Study to Evaluate Pharmacokinetics of Dipyridamole in Three New Formulations of Asasantin ER in Healthy Female and Male Subjects | Terminated | No Results Available | Healthy | Drug: Asasantin ER (new formulation - low)|Drug: Asasantin ER (new formulation - medium)|Drug: Asasantin ER (new formulation - high)|Drug: Asasantin ER - commercial formulation | https://ClinicalTrials.gov/show/NCT02273544 |
| 22235 | 22235 | Bioequivalence of a New Asasantin Formulation Extended Release (ER) Compared to the Commercially Available Asasantin Formulation (Aggrenox®; Extended Release) in Healthy Male and Female Volunteers | Completed | No Results Available | Healthy | Drug: Asasantin ER, new formulation|Drug: Asasantin ER, present commercial formulation | https://ClinicalTrials.gov/show/NCT02273531 |
| 22236 | 22236 | Study to Compare the Pharmacokinetics of Dipyridamole in Three Different Asasantin Extended Release (ER) Formulations in Healthy Male and Female Volunteers | Completed | No Results Available | Healthy | Drug: Asasantin ER, new formulation I|Drug: Asasantin ER, new formulation II|Drug: Asasantin ER, present commercial formulation | https://ClinicalTrials.gov/show/NCT02273518 |
| 22237 | 22237 | Comparison of Pharmacokinetics of Dipyridamole in Asasantin Extended Release (ER) and in a Combination of Persantin Immediate Release Tablets and ASA Tablets in Healthy Subjects | Completed | No Results Available | Healthy | Drug: Asasantin (ER)|Drug: Persantin|Drug: Acetyl salicylic acid (ASA) | https://ClinicalTrials.gov/show/NCT02273505 |
| 22238 | 22238 | Impact of Food on Pharmacokinetics and Pharmacodynamics of Asasantin ER in Healthy Subjects | Completed | No Results Available | Healthy | Drug: Asasantin ER|Other: Standardized breakfast | https://ClinicalTrials.gov/show/NCT02273492 |
| 22239 | 22239 | Pharmacokinetics and Safety of Asasantin Extended Release (RAD-SP) Capsules in Japanese Healthy Male Volunteers | Completed | No Results Available | Healthy | Drug: Asasantin®|Drug: Placebo | https://ClinicalTrials.gov/show/NCT02273479 |
| 22240 | 22240 | Pharmacokinetics of Oral Desipramine With and Without Concomitant Administration of Crobenetine Infusion in Healthy Male Subjects | Completed | No Results Available | Healthy | Drug: Desipramine tablet|Drug: Crobenetine infusion|Drug: Placebo infusion | https://ClinicalTrials.gov/show/NCT02273466 |
| 22241 | 22241 | Study to Evaluate the Presence of a Hangover Effect in Healthy Adults After Administration of Songha® Night Tablets | Completed | No Results Available | Healthy | Drug: Songha® Night|Drug: Oxazepam|Drug: Placebo | https://ClinicalTrials.gov/show/NCT02273453 |
| 22242 | 22242 | Effect of BIIL 284 BS on the Pharmacokinetics of Theophylline in Healthy Male Volunteers | Completed | No Results Available | Healthy | Drug: BIIL 284 BS|Drug: Theophylline|Drug: Placebo | https://ClinicalTrials.gov/show/NCT02273440 |
| 22243 | 22243 | Effect of Different Food Compositions on Bioavailability of BIIL 284 BS in Healthy Male Volunteers | Completed | No Results Available | Healthy | Drug: BIIL 284 BS|Other: high fat meal|Other: low fat meal | https://ClinicalTrials.gov/show/NCT02273427 |
| 22244 | 22244 | Study to Investigate the Safety, Tolerability, Biological Effects and Preliminary Pharmacokinetics of Increasing Doses of BIIL 284 BS in Healthy Male Volunteers | Completed | No Results Available | Healthy | Drug: BIIL 284 BS - rising dose|Drug: Placebo | https://ClinicalTrials.gov/show/NCT02273414 |
| 22245 | 22245 | Safety, Tolerability and Pharmacokinetics of Single Rising Inhaled Doses of BI 11054 CL Administered With the Respimat® in Healthy Male Volunteers | Completed | No Results Available | Healthy | Drug: BI 11054 CL|Drug: Placebo | https://ClinicalTrials.gov/show/NCT02273401 |
| 22246 | 22246 | BI 6727 Administered Intravenously Every 3 Weeks in Patients With Solid Tumours | Active, not recruiting | No Results Available | Neoplasms | Drug: BI 6727 | https://ClinicalTrials.gov/show/NCT02273388 |
| 22247 | 22247 | Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC | Recruiting | No Results Available | Non-Small Cell Lung Cancer | Drug: MEDI4736|Drug: Placebo | https://ClinicalTrials.gov/show/NCT02273375 |
| 22248 | 22248 | Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver Undergoing Surgery | Recruiting | No Results Available | Adult Liver Carcinoma | Drug: Erlotinib Hydrochloride|Other: Laboratory Biomarker Analysis|Other: Quality-of-Life Assessment | https://ClinicalTrials.gov/show/NCT02273362 |
| 22249 | 22249 | Lung Volume Reduction Coils for Emphysema in Alpha-1 Antitrypsin Deficiency | Recruiting | No Results Available | Alpha-1-Antitrypsin Deficiency|Chronic Obstructive Lung Disease|Emphysema | Device: Lung Volume Reduction Coil (PneumrX Inc.) | https://ClinicalTrials.gov/show/NCT02273349 |
| 22250 | 22250 | Comprehensive Genomic Analysis in Tissue and Blood Samples From Young Patients With Lung Cancer | Recruiting | No Results Available | Non-small Cell Lung Cancer|Small Cell Lung Cancer | Other: cytology specimen collection procedure|Other: laboratory biomarker analysis | https://ClinicalTrials.gov/show/NCT02273336 |
| 22251 | 22251 | Flow Mediated Dilation in Response to Black Tea | Recruiting | No Results Available | Vascular Function | Other: Tea|Other: Placebo | https://ClinicalTrials.gov/show/NCT02273323 |
| 22252 | 22252 | Families Taking Control (FTC): Family-based Problem-solving Intervention for Children With Sickle Cell Disease | Completed | No Results Available | Sickle Cell Disease | Behavioral: Problem Solving Training for Disease Management | https://ClinicalTrials.gov/show/NCT02273310 |
| 22253 | 22253 | Healthy Start: Exploring the Fuel-mediated Programming of Neonatal Growth | Active, not recruiting | No Results Available | Pregnancy|Obesity | Other: Maternal factors | https://ClinicalTrials.gov/show/NCT02273297 |
| 22254 | 22254 | Pain Perception of Children and Youth Receiving Non-sedated Botulinum Toxin-A Injections Using the Buzzy® | Recruiting | No Results Available | Pain | Device: Buzzy | https://ClinicalTrials.gov/show/NCT02273284 |
| 22255 | 22255 | Evaluation of FLT-PET and DWI-MRI in Patients With NSCLC Treated With a Platinum-based Doublet as Preoperative Chemo | Not yet recruiting | No Results Available | Non-small Cell Lung Carcinoma | Other: 18F-FLT-PET/CT and DWI-MRI | https://ClinicalTrials.gov/show/NCT02273271 |
| 22256 | 22256 | A Study to Compare Pharmacokinetics and Pharmacodynamics of SAR342434 to Insulin Lispro in Subjects With Type 1 Diabetes | Completed | No Results Available | Type 1 Diabetes | Drug: SAR342434|Drug: Insulin Lispro|Drug: Insulin Lispro | https://ClinicalTrials.gov/show/NCT02273258 |
| 22257 | 22257 | Is a Pre-contrast Scan Necesary to Diagnose Acute Aortic Syndrome? | Not yet recruiting | No Results Available | Acute Aortic Syndrome | Radiation: Thoracic aortogram CT | https://ClinicalTrials.gov/show/NCT02273245 |
| 22258 | 22258 | Effects of Remote Ischemic Preconditioning on Moderate PVD Patients A Pilot Randomized Control Trial | Recruiting | No Results Available | Peripheral Arterial Diseases | Other: Remote Ischemic Preconditioning|Other: Supervised Exercise|Other: Standard Care | https://ClinicalTrials.gov/show/NCT02273232 |
| 22259 | 22259 | Trial of AEB071 in Combination With BYL719 in Patients With Melanoma | Recruiting | No Results Available | Uveal Melanoma | Drug: AEB071|Drug: BYL719 | https://ClinicalTrials.gov/show/NCT02273219 |
| 22260 | 22260 | Collaborative Care to Reduce Depression and Increase Cancer Screening Among Low-Income Urban Women Project (Prevention Care Manager 3 Project) | Recruiting | No Results Available | Depression|Breast Cancer Screening|Cervical Cancer Screening|Colorectal Cancer Screening | Behavioral: Preventive Care Management for Depression|Behavioral: Preventive Care Management for Cancer Screening | https://ClinicalTrials.gov/show/NCT02273206 |